Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00013221 · ClinicalTrials.gov registry record · Phase 4
Exercise Effect on Aerobic Capacity and QOL in Heart Failure
A Phase 4 study of Heart Failure, Congestive, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT00013221: Completed Phase 4 study of Heart Failure, Congestive, sponsored by US Department of Veterans Affairs.
NCT00013221 is a Phase 4 study of Heart Failure, Congestive that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 84 participants, below the 673-participant average among 39 other Heart Failure, Congestive trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00013221, a Phase 4 study of Heart Failure, Congestive, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic heart failure (HF) is a syndrome of impaired ventricular function resulting in clinical symptoms of fatigue, dyspnea, and decreased exercise capacity. These symptoms lead to a cyclical pattern of an increasing sedentary lifestyle with accompanying deconditioning and deterioration of muscle function. Until recently, the prescription for individuals with HF was rest and minimization of physical exertion.
Conditions Studied
Interventions
- BEHAVIORAL Exercise
Study Locations (1)
Illinois
- Edward Hines Jr. VA Hospital, Hines, IL - Hines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Est. Completion | 2000-03 |
| Phase | Phase 4 |
What the finished NCT00013221 record still lists
NCT00013221 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 673-participant average among 39 other Heart Failure, Congestive trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Heart Failure, Congestive appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.
NCT00013221 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00013221 about?
NCT00013221 is a clinical study titled "Exercise Effect on Aerobic Capacity and QOL in Heart Failure". Chronic heart failure (HF) is a syndrome of impaired ventricular function resulting in clinical symptoms of fatigue, dyspnea, and decreased exercise capacity. These symptoms lead to a cyclical pattern of an increasing sedentary lifestyle with accompanying deconditioning and deterioration of muscle f...
What is the current status of trial NCT00013221?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 84 participants. Estimated completion is 2000-03.
What conditions does trial NCT00013221 study?
This clinical trial studies the following conditions: Heart Failure, Congestive.
What interventions are being tested in trial NCT00013221?
The interventions under investigation include: Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT00013221?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00013221 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure, Congestive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00013221's enrollment target sits among peer trials
84 25th of 39 higher than 15 of 39 other Heart Failure, Congestive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure, Congestive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
RECRUITING · Phase 4
-
Effects of Carvedilol on Health Outcomes in Heart Failure
COMPLETED · Phase 4
-
Statin Therapy in Heart Failure: Potential Mechanisms of Benefit
COMPLETED · Phase 4
-
The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure
COMPLETED · Phase 4
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma